BIOMARIN PHARMACEUTICAL BioMarin Pharmaceutical Inc

BIOMARIN PHARMACEUTICAL BioMarin Pharmaceutical Inc is a security (CUSIP 09061GAH4) tracked across SEC portfolio filings. 2 registered fund positions totaling $194K via N-PORT as of 2023-02-28.

Summary

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Delaware Enhanced Global Dividend & Income FundDelaware Enhanced Global Dividend & Income Fund$128K19.42%
Delaware Investments Dividend & Income Fund, IncDelaware Investments Dividend & Income Fund, Inc$65K9.85%

More